Showing 3,121 - 3,140 results of 10,572 for search '"tumors"', query time: 0.09s Refine Results
  1. 3121

    MRI Features with Pathologic Correlation of Primary Ovarian Carcinoid: A Case Report by Bon Jae Koo, Seong Kuk Yoon, Min Gyoung Pak, Kyeong Ah Kim

    Published 2025-01-01
    “…Primary ovarian carcinoid tumors are rare well-differentiated neuroendocrine tumors classified as monodermal teratomas. …”
    Get full text
    Article
  2. 3122

    Goblet Cell Carcinoid in a Patient with Neurofibromatosis Type 1: A Rare Combination by Tine Gregersen, Nanna Holt, Henning Gronbaek, Ida Vogel, Lars J. Jørgensen, Klaus Krogh

    Published 2012-01-01
    “…Neuroendocrine tumors are rare tumors primarily located in the gastrointestinal tract. …”
    Get full text
    Article
  3. 3123

    MiRNAs as major players in brain health and disease: current knowledge and future perspectives by Sarika V. Kapplingattu, Sujata Bhattacharya, Yogita K. Adlakha

    Published 2025-01-01
    “…Several reports show downregulation of miR-135 in glioblastoma, indicating its tumor suppressor role in the pathogenesis of brain tumors. …”
    Get full text
    Article
  4. 3124

    Clinically relevant orthotopic pancreatic cancer models for adoptive T cell transfer therapy by Gregory B. Lesinski, Chrystal M. Paulos, Maggie Phillips, Jacklyn Hammons, Isaac Karpovsky, Zaid Mahdi, Natalie K. Horvat, Megan M. Wyatt, Margaret A. Hall, Cameron J. Herting, Richard A. Moffitt

    Published 2024-01-01
    “…Interestingly, we found that chimeric antigen receptor (CAR) T cells redirected to recognize mesothelin on these tumors that signal via CD3ζ and 41BB (Meso-41BBζ-CAR T cells) infiltrated the tumors of mice bearing stroma-devoid KPC-Luc orthotopic tumors, but not MT-5 tumors.Conclusions Our data establish for the first time a reproducible and realistic clinical system useful for modeling stroma-rich and stroma-devoid PDAC tumors. …”
    Get full text
    Article
  5. 3125

    Prognostic and Risk Factors in Patients with Locally Advanced Cutaneous Squamous Cell Carcinoma of the Trunk and Extremities by de Lima Vazquez Vinicius, Cristovam Scapulatempo, Natalia Martins Perpetuo, Faheez Mohamed, Teóclito Sachetto de Carvalho, Antônio Talvane Torres de Oliveira, José Getúlio Martins Segalla, André Lopes Carvalho

    Published 2011-01-01
    “…Patients with T3 tumors had better cancer-specific survival (CSS) than those with T4 tumors; patients with no lymph node involvement had better CSS than patients with N1 tumors. …”
    Get full text
    Article
  6. 3126

    Prognostic factors for head and neck cancer of unknown primary including the impact of human papilloma virus infection by Lars Axelsson, Jan Nyman, Hedda Haugen-Cange, Mogens Bove, Leif Johansson, Shahin De Lara, Anikó Kovács, Eva Hammerlid

    Published 2017-06-01
    “…The majority were males, and had N2 tumors. Sixty-nine percent of the tumors were HPV positive using p16 staining. …”
    Get full text
    Article
  7. 3127

    Evaluatıon of contrast enhancement intensity, pattern, and kinetics of breast lesions on contrast-enhanced spectral mammography by Ayşe Füsun Bekirçavuşoğlu, Sibel Kul, Süleyman Bekirçavuşoğlu, Dilara Atasoy, Merve Erkan

    Published 2025-01-01
    “…Abstract Background Contrast-enhanced spectral mammography (CESM) is a new and promising imaging modality that improves tumor visibility through tumor contrast enhancement caused by malignant neovascularization. …”
    Get full text
    Article
  8. 3128

    Treatment of Basal Cell Carcinomas with Pulsed Dye Laser: A Case Series by Norman Minars, Marianna Blyumin-Karasik

    Published 2012-01-01
    “…Twenty-four patients with thirty-two tumors reached at least three months followup: 24/32 (75%) tumors with complete resolution (mean 3 treatment sessions); 5/32 (16%) tumors recurred; 3/32 (9%) tumors with incomplete responses after four treatments. …”
    Get full text
    Article
  9. 3129

    Radiosynthesis and Evaluation of 5-[I]Iodoindol-3-yl-β--Galactopyranoside as a β-Galactosidase Imaging Radioligand by Marcian E. Van Dort, Kuei C. Lee, Christin A. Hamilton, Alnawaz Rehemtulla, Brian D. Ross

    Published 2008-07-01
    “…In contrast, intratumoral injection of the substrate resulted in efficient trapping of radioactivity in D54L tumors but not D54 tumors, resulting in clear SPECT visualization of the former tumor. …”
    Get full text
    Article
  10. 3130

    Endometrial Stromal Nodule: A Rarity and a Pathological Challenge by Camilla Skovvang Borg, Peter Humaidan, Hanne Noer, Huda Galib Majeed

    Published 2015-01-01
    “…Endometrial stromal tumors are rare, and endometrial stromal nodule is the least common. …”
    Get full text
    Article
  11. 3131

    Rare Case of Multiple Perirenal, Extra-Adrenal Myelolipoma: Case Report, Current Management Options, and Literature Review by Goran Benko, Andrina Kopjar, Marin Plantak, Danijel Cvetko, Vicko Glunčić, Anita Lukić

    Published 2021-01-01
    “…Extra-adrenal myelolipomas are rare, asymptomatic entities, although large tumors may cause local symptoms or hemorrhage. When these lesions occur outside the adrenals in the retroperitoneum, they are radiographically easily confused with both primary and secondary retroperitoneal tumors, which tend to be aggressive. …”
    Get full text
    Article
  12. 3132

    Impact of the Siewert Classification on the Outcome of Patients Treated by Preoperative Chemoradiotherapy for a Nonmetastatic Adenocarcinoma of the Oesophagogastric Junction by Laurence Moureau-Zabotto, Eric Teissier, Didier Cowen, David Azria, Steve Ellis, Michel Resbeut

    Published 2015-01-01
    “…For OGJA treated with preoperative CRT and surgery, ORR and CRMR were lower for patients with Siewert I tumors in comparison with Siewert II/III tumors.…”
    Get full text
    Article
  13. 3133

    Application and Evaluation of [Tc]-Labeled Peptide Nucleic Acid Targeting in Breast Cancer Imaging by Yaqun Jiang MD, Yongkang Gai PhD, Yu Long MD, Qingyao Liu PhD, Chunbao Liu MD, PhD, Yongxue Zhang MD, Xiaoli Lan MD, PhD

    Published 2020-06-01
    “…The relative expression of miR-155 in MCF-7 cells and tumors was higher than that in MDA-MB-231 cells and tumors. …”
    Get full text
    Article
  14. 3134

    Loss of BRCA1 Spontaneously Induces the Tumorigenesis in Lacrimal Gland by Sun Eui Kim, Hye Jung Baek, Eun Jung Park, Sung Chul Lim, Sang Soo Kim

    Published 2018-01-01
    “…We have previously shown that spontaneous tumors form frequently in mice homozygous for a full-length Brca1 deletion. …”
    Get full text
    Article
  15. 3135
  16. 3136

    Hepatobiliary Cystadenocarcinoma by Neal Wilkinson

    Published 2012-01-01
    “…Biliary cystadenocarcinomas are rare tumors that are poorly understood. Preoperative imaging is imprecise and treatment is not standardized. …”
    Get full text
    Article
  17. 3137

    Exploring the heterogeneity of HER2 gene status and expression in non-positive breast cancer patients: insights from immunohistochemistry and fluorescence in situ hybridization by Jingmin Zhong, Beibei Gao, Qingjie Wang, Jun He, Danjv Luo, Chen Zhang, Jun Fan, Xiu Nie

    Published 2025-01-01
    “…Our analysis revealed that HER2-low tumors exhibited fewer grade III tumors (39.74% and 55.65%, respectively, P = 0.005) and higher positivity for estrogen receptor (ER, 88.89% vs. 61.74%, P < 0.001) and progesterone receptor (PR, 84.62% vs. 57.39%, P < 0.001) compared to HER2-ZERO tumors. …”
    Get full text
    Article
  18. 3138

    MammaPrint Feasibility in a Large Tertiary Urban Medical Center: An Initial Experience by C. Francisco Espinel, Shaughn Keating, Hanina Hibshoosh, Bret Taback, Kathie-Ann Joseph, Mahmoud El-Tamer, Sheldon Feldman

    Published 2012-01-01
    “…Out of all eligible patients, 14/50 (28%) had samples whose quantity of tumor was not sufficient for analysis (QNS). Out of eligible patients with tumors <1 cm, 7/8 (88%) had QNS samples. 7/42 with tumors ≥1 cm (17%) had QNS samples. …”
    Get full text
    Article
  19. 3139

    Treatment and Outcomes of Pancreatic Cancer in Armenia: A Retrospective Study From Resource-Limited Settings by Elen Baloyan, Davit Zohrabyan, Liana Safaryan, Armen Avagyan, Lilit Harutyunyan, Vardan Bardakhchyan, Jemma Arakelyan, Amalya Sargsyan, Martin Harutyunyan, Mariam Mailyan, Gevorg Tamamyan, Samvel Bardakhchyan

    Published 2025-01-01
    “…The main independent prognostic factor for overall survival (OS) was the TNM stage, whereas grade of the tumor was not significant. The median OS was 11 months (range, 2-169 months): In stages I-III, patients who had surgery (44.4%) lived significantly longer than those who did not (20 v 11 months; P = .008). …”
    Get full text
    Article
  20. 3140

    Sebaceous Lymphadenoma of Parotid: Imaging, Cytological, and Histological Findings in Detail by Golsa Shekarkhar, Hossein Soleimanpour, Seyed Hamed Jafari, Fatemeh Zamani

    Published 2018-01-01
    “…Sebaceous lymphadenomas are rare and account for less than 1% of primary salivary gland tumors. These rare tumors are mostly found in men older than 50 years. …”
    Get full text
    Article